Tuesday, September 2:
Anthony Davies, DHC's CEO & Founder will chair "Spotlight: Beyond Capital - what biotechs need from investors" as part of the Investor Summit.
Wednesday, September 3:
Anthony Davies, DHC's CEO & Founder will chair the Opening Plenary: "The state of the CGT industry & turning the future into action."
and
Barry J. Oliver, DHC Senior Principal, Eligible QP, MRSB will be moderating a panel on the topic of "Deconvoluting Supply Chain and Regulatory Requirements for Importation of CGT products into EU & UK."
